Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylation
- 6 August 1984
- journal article
- Published by Wiley in FEBS Letters
- Vol. 173 (2), 287-290
- https://doi.org/10.1016/0014-5793(84)80792-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Bufuralol metabolism in human liver: a sensitive probe for the debrisoquine‐type polymorphism of drug oxidationEuropean Journal of Clinical Investigation, 1984
- Assessment of the drug metabolism capacity of the liver.British Journal of Clinical Pharmacology, 1982
- The genetic controlof bufuralol metabolisminmanEuropean Journal of Drug Metabolism and Pharmacokinetics, 1982
- The Upjohn Award Lecture 1981/La Conférence Upjohn 1981: The metabolism of xenobiotics in different populationsCanadian Journal of Physiology and Pharmacology, 1982
- Defective Oxidation of DrugsClinical Pharmacokinetics, 1982
- Clinical pharmacology. Possible clinical importance of genetic differences in drug metabolism.BMJ, 1981
- Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.British Journal of Clinical Pharmacology, 1981
- A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.Journal of Medical Genetics, 1980
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977